V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20024153 | 20010260 | 1.58 | 74.8 | Adjuvant (A) | null | 2015-09-28 | FEC + DOCETAXEL | N | null | 20085394 | FEC + DOCETAXEL |
| 20024154 | 20010260 | 1.66 | 73.6 | Curative (C) | 2016-03-05 | 2016-03-09 | FEC + DOCETAXEL | 02 | N | 20085394 | FEC + DOCETAXEL |
| 20024155 | 20010260 | 1.58 | 95.9 | Adjuvant (A) | 2014-09-23 | 2014-09-23 | FEC + DOCETAXEL | 02 | N | 20085394 | FEC + DOCETAXEL |
| 20024156 | 20010261 | null | 53 | null | 2017-01-19 | 2017-02-07 | FEC + DOCETAXEL | N | null | 20085403 | FEC + DOCETAXEL |
| 20024157 | 20010261 | null | 86.85 | Adjuvant (A) | 2017-11-18 | 2017-12-02 | FEC + DOCETAXEL | N | N | 20085403 | FEC + DOCETAXEL |
| 20024158 | 20010262 | 1.6 | 123.1 | Adjuvant (A) | 2015-12-23 | 2016-01-04 | FEC + DOCETAXEL | 02 | N | 20085405 | FEC + DOCETAXEL |
| 20024159 | 20010262 | 1.71 | null | Neo-adjuvant (N) | 2014-10-13 | 2014-11-10 | FEC 100 + DOCETAXEL | N | N | 20085405 | FEC + DOCETAXEL |
| 20024160 | 20010263 | 1.66 | 81.7 | Adjuvant (A) | 2014-02-01 | 2014-02-15 | FEC + DOCETAXEL | N | N | 20085419 | FEC + DOCETAXEL |
| 20024161 | 20010263 | 1.62 | 48 | Neo-adjuvant (N) | null | 2014-04-17 | FEC + DOCETAXEL | null | N | 20085419 | FEC + DOCETAXEL |
| 20024162 | 20010264 | 1.63 | 74.5 | Adjuvant (A) | 2014-06-04 | 2014-06-04 | FEC 100 + DOCETAXEL | 02 | N | 20085424 | FEC + DOCETAXEL |
| 20024163 | 20010265 | null | 63.1 | Adjuvant (A) | 2018-03-07 | 2018-03-30 | FEC + DOCETAXEL | N | N | 20085425 | FEC + DOCETAXEL |
| 20024164 | 20010265 | 1.61 | 70.2 | Adjuvant (A) | 2014-04-05 | 2014-04-21 | FEC + DOCETAXEL | N | N | 20085425 | FEC + DOCETAXEL |
| 20024165 | 20010265 | null | 80 | Adjuvant (A) | 2014-03-19 | 2014-04-03 | FEC + DOCETAXEL | N | N | 20085425 | FEC + DOCETAXEL |
| 20024166 | 20010266 | 1.66 | 95.25 | Curative (C) | 2017-12-28 | 2017-12-29 | FEC + DOCETAXEL | 02 | N | 20085430 | FEC + DOCETAXEL |
| 20024167 | 20010266 | 1.68 | 49.6 | Adjuvant (A) | 2015-02-09 | 2015-03-03 | FEC + DOCETAXEL | 02 | N | 20085430 | FEC + DOCETAXEL |
| 20024168 | 20010267 | 1.64 | 165 | Adjuvant (A) | 2017-01-18 | 2017-01-29 | FEC + DOCETAXEL | 02 | N | 20085438 | FEC + DOCETAXEL |
| 20024169 | 20010267 | 1.52 | 61.6 | Adjuvant (A) | null | 2017-04-12 | FEC 100 + DOCETAXEL | N | N | 20085438 | FEC + DOCETAXEL |
| 20024170 | 20010268 | null | null | null | 2013-10-20 | 2013-11-03 | FEC + DOCETAXEL | N | N | 20085448 | FEC + DOCETAXEL |
| 20024171 | 20010269 | 1.69 | 61.3 | Adjuvant (A) | 2016-06-24 | 2016-07-16 | FEC + DOCETAXEL | 2 | N | 20085450 | FEC + DOCETAXEL |
| 20024172 | 20010269 | null | 80 | Adjuvant (A) | 2013-10-21 | 2013-11-04 | FEC 100 + DOCETAXEL | N | N | 20085450 | FEC + DOCETAXEL |
| 20024173 | 20010269 | 1.64 | 113 | Disease modification (D) | 2015-06-30 | 2015-07-13 | FEC 100 + DOCETAXEL | 02 | N | 20085450 | FEC + DOCETAXEL |
| 20024174 | 20010269 | 1.66 | 83.3 | Adjuvant (A) | null | 2017-12-02 | FEC + DOCETAXEL | N | null | 20085450 | FEC + DOCETAXEL |
| 20024175 | 20010270 | 1.63 | 78.5 | Adjuvant (A) | 2014-07-10 | 2014-07-17 | FEC + DOCETAXEL | 02 | N | 20085463 | FEC + DOCETAXEL |
| 20024176 | 20070932 | null | 75.4 | Adjuvant (A) | 2014-05-01 | 2014-05-02 | FEC 100 + DOCETAXEL | 02 | N | 20085465 | FEC + DOCETAXEL |
| 20024177 | 20010271 | null | 76.6 | null | null | 2016-05-15 | FEC 100 + DOCETAXEL | null | null | 20085466 | FEC + DOCETAXEL |
| 20024178 | 20010271 | 1.66 | null | Palliative (P) | 2017-09-10 | 2017-09-24 | FEC + DOCETAXEL | N | N | 20085466 | FEC + DOCETAXEL |
| 20024179 | 20010272 | null | null | Adjuvant (A) | 2017-01-09 | 2017-01-28 | FEC + DOCETAXEL | N | N | 20085468 | FEC + DOCETAXEL |
| 20024180 | 20010272 | 1.7 | 64 | Adjuvant (A) | 2014-09-19 | 2014-09-19 | FEC 100 + DOCETAXEL | 02 | N | 20085468 | FEC + DOCETAXEL |
| 20024181 | 20010273 | null | 215 | Adjuvant (A) | 2015-09-21 | 2015-09-21 | FEC + DOCETAXEL | N | N | 20085473 | FEC + DOCETAXEL |
| 20024182 | 20070935 | 1.67 | 54 | Adjuvant (A) | 2014-05-07 | 2014-05-21 | FEC + DOCETAXEL | N | N | 20085476 | FEC + DOCETAXEL |
| 20024183 | 20070935 | 1.72 | 70.6 | Neo-adjuvant (N) | 2014-07-24 | 2014-08-06 | FEC + DOCETAXEL | 02 | N | 20085476 | FEC + DOCETAXEL |
| 20024184 | 20010274 | 1.7 | 72.8 | Adjuvant (A) | 2017-12-13 | 2017-12-20 | FEC + DOCETAXEL | N | N | 20085481 | FEC + DOCETAXEL |
| 20024185 | 20010274 | 1.71 | 62.9 | Adjuvant (A) | 2016-12-15 | 2017-01-20 | FEC + DOCETAXEL | 02 | Y | 20085481 | FEC + DOCETAXEL |
| 20024186 | 20108439 | 1.57 | 91.5 | Curative (C) | null | 2015-12-23 | FEC 100 + DOCETAXEL | N | N | 20085484 | FEC + DOCETAXEL |
| 20024187 | 20010275 | 1.62 | 60 | Curative (C) | 2013-07-11 | 2013-07-12 | FEC + DOCETAXEL | 02 | N | 20085488 | FEC + DOCETAXEL |
| 20024188 | 20070937 | 1.6 | 68.7 | null | 2017-10-16 | 2017-11-08 | FEC + DOCETAXEL | 2 | null | 20085493 | FEC + DOCETAXEL |
| 20024189 | 20070937 | 1.73 | 53.6 | Adjuvant (A) | 2014-10-22 | 2014-10-26 | FEC + DOCETAXEL | 02 | N | 20085493 | FEC + DOCETAXEL |
| 20024190 | 20010276 | 1.57 | 83 | Not known (9) | 2015-11-09 | 2015-12-05 | FEC 100 + DOCETAXEL | 2 | N | 20085498 | FEC + DOCETAXEL |
| 20024191 | 20010276 | 1.73 | 93.8 | Adjuvant (A) | 2014-12-24 | 2015-01-03 | FEC + DOCETAXEL | N | N | 20085498 | FEC + DOCETAXEL |
| 20024192 | 20010277 | 1.66 | null | null | 2013-04-16 | 2013-04-30 | FEC 100 + DOCETAXEL | N | null | 20085501 | FEC + DOCETAXEL |
| 20024193 | 20070939 | null | 121 | Neo-adjuvant (N) | 2015-01-22 | 2015-01-22 | FEC + DOCETAXEL | null | N | 20085504 | FEC + DOCETAXEL |
| 20024194 | 20010278 | 1.69 | 64.2 | Not known (9) | 2014-01-01 | 2014-01-06 | FEC + DOCETAXEL | 02 | N | 20085507 | FEC + DOCETAXEL |
| 20024195 | 20010279 | null | 76 | Neo-adjuvant (N) | 2014-10-15 | 2014-10-20 | FEC 100 + DOCETAXEL | N | N | 20085509 | FEC + DOCETAXEL |
| 20024196 | 20010279 | null | null | Adjuvant (A) | 2015-11-24 | 2015-12-23 | FEC 60 OR 75 + DOCETAXEL | N | N | 20085509 | FEC + DOCETAXEL |
| 20024197 | 20010280 | null | 120.9 | Not known (9) | 2017-02-16 | 2017-03-03 | FEC 100 + DOCETAXEL | N | N | 20085513 | FEC + DOCETAXEL |
| 20024198 | 20010280 | 1.64 | 88.2 | Adjuvant (A) | 2017-06-18 | 2017-06-22 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | null | 20085513 | FEC + DOCETAXEL |
| 20024199 | 20010280 | 1.54 | 82.5 | Neo-adjuvant (N) | 2016-09-28 | 2016-10-10 | FEC + DOCETAXEL | 02 | N | 20085513 | FEC + DOCETAXEL |
| 20024200 | 20010280 | 1.71 | null | Adjuvant (A) | 2013-09-13 | 2013-10-04 | FEC + DOCETAXEL | N | N | 20085513 | FEC + DOCETAXEL |
| 20024201 | 20010281 | 1.69 | 93 | Adjuvant (A) | 2016-07-09 | 2016-07-09 | FEC + DOCETAXEL | 02 | N | 20085519 | FEC + DOCETAXEL |
| 20024202 | 20010282 | 1.61 | 59.5 | Adjuvant (A) | null | 2015-06-29 | FEC 100 + DOCETAXEL | N | N | 20085525 | FEC + DOCETAXEL |